H. Mayaudon

1.3k total citations
98 papers, 839 citations indexed

About

H. Mayaudon is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, H. Mayaudon has authored 98 papers receiving a total of 839 indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Endocrinology, Diabetes and Metabolism, 23 papers in Cardiology and Cardiovascular Medicine and 19 papers in Surgery. Recurrent topics in H. Mayaudon's work include Diabetes, Cardiovascular Risks, and Lipoproteins (13 papers), Pituitary Gland Disorders and Treatments (10 papers) and Blood Pressure and Hypertension Studies (10 papers). H. Mayaudon is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (13 papers), Pituitary Gland Disorders and Treatments (10 papers) and Blood Pressure and Hypertension Studies (10 papers). H. Mayaudon collaborates with scholars based in France, United States and Switzerland. H. Mayaudon's co-authors include B. Bauduceau, Olivier Dupuy, L. Bordier, C. Garcia, S. Halimi, P. Burnat, Franck Ceppa, Bruno Fève, Pascal Ferré and O. Dupuy and has published in prestigious journals such as Diabetes Care, Clinical Chemistry and Journal of Hypertension.

In The Last Decade

H. Mayaudon

87 papers receiving 804 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H. Mayaudon France 14 268 205 181 176 136 98 839
Mark Lankisch Germany 20 332 1.2× 482 2.4× 131 0.7× 218 1.2× 142 1.0× 36 1.1k
Kentaro Watanabe Japan 16 258 1.0× 155 0.8× 122 0.7× 259 1.5× 134 1.0× 132 989
Ľudovít Gašpar Slovakia 17 175 0.7× 217 1.1× 238 1.3× 212 1.2× 255 1.9× 92 967
Mirosława Urban Poland 14 209 0.8× 191 0.9× 95 0.5× 114 0.6× 104 0.8× 74 796
Sabrina Costa Italy 14 184 0.7× 115 0.6× 238 1.3× 105 0.6× 114 0.8× 27 694
Aída Medina-Urrutia Mexico 16 252 0.9× 205 1.0× 150 0.8× 164 0.9× 111 0.8× 56 808
Yongyan Song China 16 207 0.8× 167 0.8× 133 0.7× 221 1.3× 261 1.9× 58 834
B. A. K. Khalid Malaysia 21 534 2.0× 88 0.4× 135 0.7× 212 1.2× 203 1.5× 77 1.2k
Allison E. Norlander United States 15 381 1.4× 370 1.8× 259 1.4× 135 0.8× 249 1.8× 25 1.6k
Jang Won Son South Korea 17 270 1.0× 118 0.6× 320 1.8× 126 0.7× 199 1.5× 53 940

Countries citing papers authored by H. Mayaudon

Since Specialization
Citations

This map shows the geographic impact of H. Mayaudon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Mayaudon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Mayaudon more than expected).

Fields of papers citing papers by H. Mayaudon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Mayaudon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Mayaudon. The network helps show where H. Mayaudon may publish in the future.

Co-authorship network of co-authors of H. Mayaudon

This figure shows the co-authorship network connecting the top 25 collaborators of H. Mayaudon. A scholar is included among the top collaborators of H. Mayaudon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Mayaudon. H. Mayaudon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mayaudon, H., et al.. (2015). Le syndrome de Cushing paranéoplasique, un vrai défi diagnostique et thérapeutique : à propos d’un cas et revue de la littérature. La Revue de Médecine Interne. 36(12). 843–847. 4 indexed citations
2.
Dupuy, Olivier, et al.. (2010). Une complication inhabituelle d’un traitement anticoagulant : l’hémorragie hypophysaire. La Revue de Médecine Interne. 31(8). e1–e2. 2 indexed citations
3.
Dupuy, O., et al.. (2010). Hyperparathyroïdie et grossesse : association à risque pour la mère et l’enfant. La Revue de Médecine Interne. 31(11). e9–e10. 1 indexed citations
4.
Bellanné‐Chantelot, Christine, L. Bordier, C. Garcia, et al.. (2010). Diabète de type 2 associé à des malformations rénales et pancréatiques. La Revue de Médecine Interne. 31(6). e5–e6. 1 indexed citations
5.
Mayaudon, H., et al.. (2007). Use of Ni electrodes chronoamperometry for improved diagnostics of diabetes and cardiac diseases. Conference proceedings. 2007. 4544–4547. 20 indexed citations
6.
Bauduceau, B., H. Mayaudon, P. Burnat, et al.. (2007). Should we have more definitions of metabolic syndrome or simply take waist measurement?. Diabetes & Metabolism. 33(5). 333–339. 12 indexed citations
7.
Bordier, L., et al.. (2007). Prise en charge du syndrome de Nelson : données actuelles. La Revue de Médecine Interne. 28(11). 766–769. 4 indexed citations
8.
Bordier, L., et al.. (2006). Is Hyperhomocysteinemia an Additional Risk Factor of the Metabolic Syndrome?. Metabolic Syndrome and Related Disorders. 4(3). 185–195. 18 indexed citations
9.
Garcia, C., et al.. (2006). Thyroïdite silencieuse chez un patient traité par lithium. La Revue de Médecine Interne. 28(1). 46–47. 2 indexed citations
10.
Bordier, L., P. Burnat, Franck Ceppa, et al.. (2006). Inefficacité des bandelettes urinaires dans la recherche de néphropathie incipiens chez les diabétiques. La Presse Médicale. 35(7-8). 1117–1121. 2 indexed citations
11.
Margery, J., L. Bordier, Olivier Dupuy, et al.. (2005). Diagnostic d’un syndrome de Klinefelter trois ans après chirurgie d’exérèse d’un tératome médiastinal. La Presse Médicale. 34(15). 1078–1079.
12.
Mayaudon, H., B. Bauduceau, P. Burnat, et al.. (2005). L'hyperhomocystéinémie est-elle un facteur de risque supplémentaire du syndrome métabolique ?. La Revue de Médecine Interne. 26(9). 695–702. 8 indexed citations
13.
Bauduceau, B., F. Baigts, L. Bordier, et al.. (2005). Epidemiology of the metabolic syndrome in 2045 French military personnel (EPIMIL study). Diabetes & Metabolism. 31(4). 353–359. 37 indexed citations
14.
Puel, Jean‐Luc, Paul Valensi, G. Vanzetto, et al.. (2004). Identification de l'ischémie myocardique chez le diabétique. Archives Des Maladies Du Coeur Et Des Vaisseaux. 97(4). 2 indexed citations
15.
Puel, Jean‐Luc, Paul Valensi, G. Vanzetto, et al.. (2004). Identification of myocardial ischemia in the diabetic patient Joint ALFEDIAM and SFC recommendations. Diabetes & Metabolism. 30(2). 3S3–3S18. 39 indexed citations
16.
Bauduceau, B., H. Mayaudon, & O. Dupuy. (2000). La pression artérielle optimale chez le diabétique. Sang thrombose vaisseaux. 12(4). 226–231.
17.
Bauduceau, B., H. Mayaudon, & Olivier Dupuy. (2000). Rilmenidine in the Hypertensive Type-2 Diabetic: A Controlled Pilot Study versus Captopril. European Journal of Cardiovascular Prevention & Rehabilitation. 7(1). 57–61. 12 indexed citations
18.
Ceppa, Franck, et al.. (2000). High-performance liquid chromatographic determination of cotinine in urine in isocratic mode. Journal of Chromatography B Biomedical Sciences and Applications. 746(2). 115–122. 33 indexed citations
19.
Maghraoui, A. El, et al.. (1999). Syndrome de Fahr et hyperparathyroïdie.. La Presse Médicale. 28(13). 689–689. 3 indexed citations
20.
Poirier, Jennifer, et al.. (1997). Epidemiological aspects of diabetes in Cameroon: what is the role of tropical diabetes?. PubMed. 23(1). 61–7. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mark Lankisch Breakdown of academic impact, for papers by Kentaro Watanabe Breakdown of academic impact, for papers by Ľudovít Gašpar Breakdown of academic impact, for papers by Mirosława Urban Breakdown of academic impact, for papers by Sabrina Costa Breakdown of academic impact, for papers by Aída Medina-Urrutia Breakdown of academic impact, for papers by Yongyan Song Breakdown of academic impact, for papers by B. A. K. Khalid Breakdown of academic impact, for papers by Allison E. Norlander Breakdown of academic impact, for papers by Jang Won Son
Rankless by CCL
2026